Toxicity after external beam radiotherapy for prostate cancer: An analysis of late morbidity in men with diabetes mellitus

Urology

Volumn 81, Issue 6, 2013, Pages 1196-1201

  Kalakota, Kapila ^b   Liauw, Stanley L ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIDIARRHEAL AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ANTICOAGULATION; ARTICLE; BLOOD TRANSFUSION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CAUTERIZATION; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DIARRHEA; DIET THERAPY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL DISEASE; GLEASON SCORE; HEMATURIA; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; INTERNATIONAL PROSTATE SYMPTOM SCORE; INTESTINE MOTILITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE VOLUME; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; TENESMUS; TOXICITY; TRANSURETHRAL RESECTION; TREATMENT DURATION; URINARY DYSFUNCTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CONSTRICTION, PATHOLOGIC; DIABETES COMPLICATIONS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TRACT; HEMATURIA; HUMANS; KAPLAN-MEIER ESTIMATE; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL DISEASES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UROGENITAL SYSTEM;

EID: 84878580518     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.01.047     Document Type: Article

References (20)

1. A. Jemal, R. Siegel, and J. Xu Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. th ed. 2012 McGraw-Hill New York
3. M. Turina, D.E. Fry, and H.C. Polk Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects Crit Care Med 33 2005 1624 1633
4. K.S. Peairs, B.B. Barone, and C.F. Snyder Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis J Clin Oncol 29 2011 40 46
5. K.B. Stein, C.F. Snyder, and B.B. Barone Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis Dig Dis Sci 55 2010 1839 1851
6. D.M. Herold, A.L. Hanlon, and G.E. Hanks Diabetes mellitus: a predictor for late radiation morbidity Int J Radiat Oncol Biol Phys 43 1999 475 479
7. T.E. Schultheiss, W.R. Lee, and M.A. Hunt Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
8. M.J. Zelefsky, D. Cowen, and Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468
9. T. Akimoto, H. Muramatsu, and M. Takahashi Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding Int J Radiat Oncol Biol Phys 60 2004 1033 1039
10. S.J. Feigenberg, A.L. Hanlon, and E.M. Horwitz Long-term androgen deprivation increases grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 62 2005 397 405
11. J. Mohler, R.J. Babaian, and R.R. Bahnson Prostate cancer: clinical practice guidelines in oncology J Natl Compr Cancer Netw 5 2007 650 683
12. S.L. Liauw, R.R. Weichselbaum, and C. Rash Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer Technol Cancer Res Treat 8 2009 201 206
13. B.B. Barone, H.-C. Yeh, and C.F. Snyder Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus JAMA 300 2008 2754 2764
14. H.B. Stone, C.N. Coleman, and M.S. Anscher Effects of radiation on normal tissue: consequences and mechanisms Lancet Oncol 4 2003 529 536
15. D. Teber, M. Sofikerim, and M. Ates Is type 2 diabetes mellitus a predictive factor for incontinence after laparoscopic radical prostatectomy? A matched pair and multivariate analysis J Urol 183 2010 1087 1091
16. T. Marien, A. Sankin, and H. Lepor Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy J Urol 181 2009 1817 1822
17. M.J. Zelefsky, H. Chan, and M. Hunt Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 176 2006 1415 1419
18. S. Gill, J. Thomas, and C. Fox Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy Radiat Oncol 6 2011 145 151
19. A.E. Pederson, J. Fricano, and D. Correa Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity Int J Radiat Oncol Biol Phys 82 2012 235 241
20. A. Pollack, G. Walker, and M. Buyyounouski Five-year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer Int J Radiat Oncol Biol Phys 81 suppl 2011 S1